{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:21:04Z","timestamp":1789816864520,"version":"4.0.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/ja.2017.102","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T05:42:52Z","timestamp":1504676572000},"page":"1033-1042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Suppressive drug combinations and their potential to combat antibiotic resistance"],"prefix":"10.1038","volume":"70","author":[{"given":"Nina","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"BFja2017102_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1126\/science.321.5887.356","volume":"321","author":"G Taubes","year":"2008","unstructured":"Taubes, G. The bacteria fight back. Science 321, 356\u2013361 (2008).","journal-title":"Science"},{"key":"BFja2017102_CR2","volume-title":"The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers","author":"SB Levy","year":"2002","unstructured":"Levy, S. B. The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers, Perseus Publishing, USA, (2002)."},{"key":"BFja2017102_CR3","doi-asserted-by":"publisher","DOI":"10.1201\/9780824744939","volume-title":"Bacterial Resistance to Antimicrobials: Mechanisms, Genetics, Medical Practice and Public Health","author":"K Lewis","year":"2001","unstructured":"Lewis, K, Salyers, A, Taber, H & Wax, R. Bacterial Resistance to Antimicrobials: Mechanisms, Genetics, Medical Practice and Public Health, Marcel Dekker, New York, (2001)."},{"key":"BFja2017102_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09657","volume":"469","author":"A Koul","year":"2011","unstructured":"Koul, A., Arnoult, E., Lounis, N., Guillemont, J. & Andries, K. The challenge of new drug discovery for tuberculosis. Nature 469, 483\u2013490 (2011).","journal-title":"Nature"},{"key":"BFja2017102_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/nbt1266","volume":"24","author":"J Clardy","year":"2006","unstructured":"Clardy, J., Fischbach, M. A. & Walsh, C. T. New antibiotics from bacterial natural products. Nat. Biotechnol. 24, 1541\u20131550 (2006).","journal-title":"Nat. Biotechnol."},{"key":"BFja2017102_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1517\/13543780903505092","volume":"19","author":"G Devasahayam","year":"2010","unstructured":"Devasahayam, G., Scheld, W. M. & Hoffman, P. S. Newer antibacterial drugs for a new century. Expert Opin. Invest. Drugs 19, 215\u2013234 (2010).","journal-title":"Expert Opin. Invest. Drugs"},{"key":"BFja2017102_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"SM Drawz","year":"2010","unstructured":"Drawz, S. M. & Bonomo, R. A. Three decades of \u03b2-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160\u2013201 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFja2017102_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nchembio.2176","volume":"12","author":"LK Stone","year":"2016","unstructured":"Stone, L. K., Baym, M., Lieberman, T. D., Chait, R., Clardy, J. & Kishony, R. Compounds that select against the tetracycline-resistance efflux pump. Nat. Chem. Biol. 12, 902\u2013904 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"BFja2017102_CR9","unstructured":"Everitt, E., Han, E., Cherian, S., Kempf, D., Sham, H. & Ng, S.-C. Compositions and methods for enhancing the bioavailability of pharmaceutical agents. Google Patents (2002)."},{"key":"BFja2017102_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0278-6915(03)00186-8","volume":"41","author":"B Ali","year":"2003","unstructured":"Ali, B. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food Chem. Toxicol. 41, 1447\u20131452 (2003).","journal-title":"Food Chem. Toxicol."},{"key":"BFja2017102_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts, J. A. et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect. Dis. 14, 498\u2013509 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"BFja2017102_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2017102_CR13","first-page":"45","volume":"21","author":"JA Perry","year":"2014","unstructured":"Perry, J. A. The antibiotic resistome: what\u2019s new? Curr. Opin. Biol. 21, 45\u201350 (2014).","journal-title":"Curr. Opin. Biol."},{"key":"BFja2017102_CR14","doi-asserted-by":"crossref","unstructured":"Boeckel, T. P. V. et al. Global trends in antimicrobial use in food animals. Proc. Natl Acad. Sci. USA 112 (2015).","DOI":"10.1073\/pnas.1503141112"},{"key":"BFja2017102_CR15","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym, M., Stone, L. K. & Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351, aad3292 (2016).","journal-title":"Science"},{"key":"BFja2017102_CR16","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1073\/pnas.082188899","volume":"99","author":"DL Smith","year":"2002","unstructured":"Smith, D. L., Harris, A. D., Johnson, J. A., Silbergeld, E. K. & Morris, J. G. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc. Natl Acad. Sci. USA 99, 6434\u20136439 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017102_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1128\/AAC.48.2.477-483.2004","volume":"48","author":"GW Stone","year":"2004","unstructured":"Stone, G. W. et al. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by \u03b2-lactamases. Antimicrob. Agents Chemother. 48, 477\u2013483 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR18","doi-asserted-by":"publisher","first-page":"262ra156","DOI":"10.1126\/scitranslmed.3009940","volume":"6","author":"C Munck","year":"2014","unstructured":"Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H. & Sommer, M. O. Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci. Transl. Med. 6, 262ra156\u2013262ra156 (2014).","journal-title":"Sci. Transl. Med."},{"key":"BFja2017102_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0753-3322(99)80063-8","volume":"53","author":"R Shafer","year":"1999","unstructured":"Shafer, R. & Vuitton, D. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomed. Pharmacother. 53, 73\u201386 (1999).","journal-title":"Biomed. Pharmacother."},{"key":"BFja2017102_CR20","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1128\/AAC.00474-11","volume":"55","author":"S Ram\u00f3n-Garc\u00eda","year":"2011","unstructured":"Ram\u00f3n-Garc\u00eda, S. et al. Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob. Agents Chemother. 55, 3861\u20133869 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR21","doi-asserted-by":"crossref","unstructured":"Bozic, I. et al. Evolutionary dynamics of cancer in response to targeted combination therapy. eLife 2 (2013).","DOI":"10.7554\/eLife.00747"},{"key":"BFja2017102_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith, C. T., Borisy, A. A. & Stockwell, B. R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 4, 71\u201378 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja2017102_CR23","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/nprot.2014.127","volume":"9","author":"H Braberg","year":"2014","unstructured":"Braberg, H. et al. Quantitative analysis of triple-mutant genetic interactions. Nat. Protoc. 9, 1867\u20131881 (2014).","journal-title":"Nat. Protoc."},{"key":"BFja2017102_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ng1755","volume":"38","author":"P Yeh","year":"2006","unstructured":"Yeh, P., Tschumi, A. I. & Kishony, R. Functional classification of drugs by properties of their pairwise interactions. Nat. Genet. 38, 489\u2013494 (2006).","journal-title":"Nat. Genet."},{"key":"BFja2017102_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.chembiol.2014.02.012","volume":"21","author":"M Cokol","year":"2014","unstructured":"Cokol, M. et al. Large-scale identification and analysis of suppressive drug interactions. Chem. Biol. 21, 541\u2013551 (2014).","journal-title":"Chem. Biol."},{"key":"BFja2017102_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/archinte.1951.03810100073006","volume":"88","author":"MH Lepper","year":"1951","unstructured":"Lepper, M. H. & Dowling, H. F. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin: studies including observations on an apparent antagonism between penicillin and aureomycin. AMA Arch. Int. Med. 88, 489\u2013494 (1951).","journal-title":"AMA Arch. Int. Med."},{"key":"BFja2017102_CR27","doi-asserted-by":"crossref","unstructured":"Foucquier, J. & Guedj, M. Analysis of drug combinations: current methodological landscape. Pharmacol. Res. Perspect. 3 (2015).","DOI":"10.1002\/prp2.149"},{"key":"BFja2017102_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"C Bliss","year":"1939","unstructured":"Bliss, C. The toxicity of poisons applied jointly1. Ann. Appl. Biol. 26, 585\u2013615 (1939).","journal-title":"Ann. Appl. Biol."},{"key":"BFja2017102_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nature05685","volume":"446","author":"R Chait","year":"2007","unstructured":"Chait, R., Craney, A. & Kishony, R. Antibiotic interactions that select against resistance. Nature 446, 668\u2013671 (2007).","journal-title":"Nature"},{"key":"BFja2017102_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/bmj.2.617.457","volume":"2","author":"TR Fraser","year":"1872","unstructured":"Fraser, T. R. Lecture on the antagonism between the actions of active substances. Br. Med. J. 2, 457 (1872).","journal-title":"Br. Med. J."},{"key":"BFja2017102_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1017\/S0370164600042565","volume":"7","author":"TR Fraser","year":"1872","unstructured":"Fraser, T. R. 5. An experimental research on the antagonism between the actions of physostigma and atropia. Proc. R. Soc. Edinburgh 7, 506\u2013511 (1872).","journal-title":"Proc. R. Soc. Edinburgh"},{"key":"BFja2017102_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3565(25)05476-X","volume":"27","author":"S Weiss","year":"1926","unstructured":"Weiss, S. Persistence of action of physostigmin and the atropin-physostigmin antagonism in animals and in man. J. Pharmacol. Exp. Ther. 27, 181\u2013188 (1926).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFja2017102_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/path.1700250311","volume":"25","author":"C Browning","year":"1922","unstructured":"Browning, C. & Gulbransen, R. An interference phenomenon in the action of chemotherapeutic substances in experimental trypanosome infections. J. Pathol. Bacteriol. 25, 395\u2013397 (1922).","journal-title":"J. Pathol. Bacteriol."},{"key":"BFja2017102_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00139709-200625020-00004","volume":"25","author":"A Proudfoot","year":"2006","unstructured":"Proudfoot, A. The early toxicology of physostigmine. Toxicol. Rev. 25, 99\u2013138 (2006).","journal-title":"Toxicol. Rev."},{"key":"BFja2017102_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nrmicro2133","volume":"7","author":"PJ Yeh","year":"2009","unstructured":"Yeh, P. J., Hegreness, M. J., Aiden, A. P. & Kishony, R. Drug interactions and the evolution of antibiotic resistance. Nat. Rev. Microbiol. 7, 460\u2013466 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja2017102_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/msb4100133","volume":"3","author":"P Yeh","year":"2007","unstructured":"Yeh, P. & Kishony, R. Networks from drug\u2013drug surfaces. Mol. Syst. Biol. 3, 85 (2007).","journal-title":"Mol. Syst. Biol."},{"key":"BFja2017102_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.chembiol.2014.04.004","volume":"21","author":"MG de Vos","year":"2014","unstructured":"de Vos, M. G. & Bollenbach, T. Suppressive drug interactions between antifungals. Chem. Biol. 21, 439\u2013440 (2014).","journal-title":"Chem. Biol."},{"key":"BFja2017102_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","volume":"141","author":"B Stechmann","year":"2010","unstructured":"Stechmann, B. et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141, 231\u2013242 (2010).","journal-title":"Cell"},{"key":"BFja2017102_CR39","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.0800944105","volume":"105","author":"J-B Michel","year":"2008","unstructured":"Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C. & Kishony, R. Drug interactions modulate the potential for evolution of resistance. Proc. Natl Acad. Sci. USA 105, 14918\u201314923 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017102_CR40","doi-asserted-by":"publisher","first-page":"e15179","DOI":"10.1371\/journal.pone.0015179","volume":"5","author":"R Chait","year":"2010","unstructured":"Chait, R., Shrestha, S., Shah, A. K., Michel, J.-B. & Kishony, R. A differential drug screen for compounds that select against antibiotic resistance. PLoS ONE 5, e15179 (2010).","journal-title":"PLoS ONE"},{"key":"BFja2017102_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/msb.2011.71","volume":"7","author":"M Cokol","year":"2011","unstructured":"Cokol, M et al. Systematic exploration of synergistic drug pairs. Mol. Syst. Biol. 7, 544 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"BFja2017102_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/1758-2229.12190","volume":"6","author":"K Mitosch","year":"2014","unstructured":"Mitosch, K. & Bollenbach, T. Bacterial responses to antibiotics and their combinations. Environ. Microbiol. Rep. 6, 545\u2013557 (2014).","journal-title":"Environ. Microbiol. Rep."},{"key":"BFja2017102_CR43","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/ncomms5296","volume":"5","author":"AC Palmer","year":"2014","unstructured":"Palmer, A. C. & Kishony, R. Opposing effects of target overexpression reveal drug mechanisms. Nat. Commun. 5, 4296 (2014).","journal-title":"Nat. Commun."},{"key":"BFja2017102_CR44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2009.10.025","volume":"139","author":"T Bollenbach","year":"2009","unstructured":"Bollenbach, T., Quan, S., Chait, R. & Kishony, R. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139, 707\u2013718 (2009).","journal-title":"Cell"},{"key":"BFja2017102_CR45","doi-asserted-by":"publisher","first-page":"13977","DOI":"10.1073\/pnas.0805965105","volume":"105","author":"M Hegreness","year":"2008","unstructured":"Hegreness, M., Shoresh, N., Damian, D., Hartl, D. & Kishony, R. Accelerated evolution of resistance in multidrug environments. Proc. Natl Acad. Sci. USA 105, 13977\u201313981 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017102_CR46","first-page":"e02268","volume":"6","author":"J Haaber","year":"2015","unstructured":"Haaber, J., Friberg, C., McCreary, M., Lin, R., Cohen, S. N. & Ingmer, H. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure. Mbio 6, e02268\u2013e03214 (2015).","journal-title":"Mbio"},{"key":"BFja2017102_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.15252\/msb.20156098","volume":"11","author":"G Chevereau","year":"2015","unstructured":"Chevereau, G. & Bollenbach, T. Systematic discovery of drug interaction mechanisms. Mol. Syst. Biol. 11, 807 (2015).","journal-title":"Mol. Syst. Biol."},{"key":"BFja2017102_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/bies.200900128","volume":"32","author":"AE Motter","year":"2010","unstructured":"Motter, A. E. Improved network performance via antagonism: from synthetic rescues to multi\u2010drug combinations. Bioessays 32, 236\u2013245 (2010).","journal-title":"Bioessays"},{"key":"BFja2017102_CR49","first-page":"1","volume":"28","author":"M Berenbaum","year":"1977","unstructured":"Berenbaum, M. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin. Exp. Immunol. 28, 1 (1977).","journal-title":"Clin. Exp. Immunol."},{"key":"BFja2017102_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","volume":"253","author":"A Bell","year":"2005","unstructured":"Bell, A. Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiol. Lett. 253, 171\u2013184 (2005).","journal-title":"FEMS Microbiol. Lett."},{"key":"BFja2017102_CR51","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.1152\/ajpendo.00308.2012","volume":"304","author":"N Geary","year":"2013","unstructured":"Geary, N. Understanding synergy. Am. J. Physiol. Endocrinol. Metab. 304, E237\u2013E253 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFja2017102_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s000490050037","volume":"9","author":"AC Nelson","year":"1999","unstructured":"Nelson, A. C. & Kursar, T. A. Interactions among plant defense compounds: a method for analysis. Chemoecology 9, 81\u201392 (1999).","journal-title":"Chemoecology"},{"key":"BFja2017102_CR53","doi-asserted-by":"publisher","first-page":"0332","DOI":"10.1098\/rsif.2016.0332","volume":"13","author":"E Tekin","year":"2016","unstructured":"Tekin, E., Beppler, C., White, C., Mao, Z., Savage, V. M. & Yeh, P. J. Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs. J. R. Soc. Interface 13 (2016) 0332 (2016).","journal-title":"J. R. Soc. Interface"},{"key":"BFja2017102_CR54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1128\/AAC.03502-14","volume":"59","author":"A Zhou","year":"2015","unstructured":"Zhou, A. et al. Synergistic interactions of vancomycin with different antibiotics against escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli. Antimicrob. Agents Chemother. 59, 276\u2013281 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ja.2016.26","volume":"69","author":"C Nguyen","year":"2016","unstructured":"Nguyen, C., Zhou, A., Khan, A., Miller, J. H. & Yeh, P. Pairwise antibiotic interactions in Escherichia coli: triclosan, rifampicin and aztreonam with nine other classes of antibiotics. J. Antibiot. 69, 791\u2013797 (2016).","journal-title":"J. Antibiot."},{"key":"BFja2017102_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X. & Chen, Y. Z. Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111\u2013128 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja2017102_CR57","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1989.7.6.710","volume":"7","author":"CK Osborne","year":"1989","unstructured":"Osborne, C. K., Kitten, L. & Arteaga, C. L. Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens. J. Clin. Oncol. 7, 710\u2013717 (1989).","journal-title":"J. Clin. Oncol."},{"key":"BFja2017102_CR58","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.291.6496.636","volume":"291","author":"GL French","year":"1985","unstructured":"French, G. L., Ling, T. K., Davies, D. P. & Leung, D. T. Antagonism of ceftazidime by chloramphenicol in vitro and in vivo during treatment of gram negative meningitis. Br. Med. J. (Clin. Res. Ed.) 291 636\u2013637 (1985).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFja2017102_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","volume":"106","author":"DM Jonker","year":"2005","unstructured":"Jonker, D. M., Visser, S. A. G., van der Graaf, Piet, H., Voskuyl, R. A. & Danhof, M. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacol. Ther. 106, 1\u201318 (2005).","journal-title":"Pharmacol. Ther."},{"key":"BFja2017102_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1128\/AAC.49.1.45-51.2005","volume":"49","author":"C Jacqueline","year":"2005","unstructured":"Jacqueline, C et al. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49, 45\u201351 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR61","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1007\/s11095-015-1632-3","volume":"32","author":"SG Wicha","year":"2015","unstructured":"Wicha, S. G., Kees, M. G., Kuss, J. & Kloft, C. Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus. Pharm. Res. 32, 2410\u20132418 (2015).","journal-title":"Pharm. Res."},{"key":"BFja2017102_CR62","doi-asserted-by":"publisher","first-page":"e1003300","DOI":"10.1371\/journal.ppat.1003300","volume":"9","author":"P Ankomah","year":"2013","unstructured":"Ankomah, P., Johnson, P. J. & Levin, B. R. The pharmaco\u2013, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations. PLoS Pathog. 9, e1003300 (2013).","journal-title":"PLoS Pathog."},{"key":"BFja2017102_CR63","doi-asserted-by":"publisher","first-page":"e1000796","DOI":"10.1371\/journal.pcbi.1000796","volume":"6","author":"JP Torella","year":"2010","unstructured":"Torella, J. P., Chait, R. & Kishony, R. Optimal drug synergy in antimicrobial treatments. PLoS Comput. Biol. 6, e1000796 (2010).","journal-title":"PLoS Comput. Biol."},{"key":"BFja2017102_CR64","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1128\/AAC.43.7.1756","volume":"43","author":"Y Dong","year":"1999","unstructured":"Dong, Y., Zhao, X., Domagala, J. & Drlica, K. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 1756\u20131758 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR65","doi-asserted-by":"publisher","first-page":"e1001540","DOI":"10.1371\/journal.pbio.1001540","volume":"11","author":"R Pena-Miller","year":"2013","unstructured":"Pena-Miller, R. et al. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biol. 11, e1001540 (2013).","journal-title":"PLoS Biol."},{"key":"BFja2017102_CR66","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tibtech.2007.09.004","volume":"25","author":"G Cottarel","year":"2007","unstructured":"Cottarel, G. & Wierzbowski, J. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol. 25, 547\u2013555 (2007).","journal-title":"Trends Biotechnol."},{"key":"BFja2017102_CR67","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/AAC.02463-14","volume":"58","author":"PS Ocampo","year":"2014","unstructured":"Ocampo, P. S. et al. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob. Agents Chemother. 58, 4573\u20134582 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jac\/24.3.311","volume":"24","author":"D Dance","year":"1989","unstructured":"Dance, D., Wuthiekanun, V., Chaowagul, W. & White, N. Interactions in vitro between agents used to treat melioidosis. J. Antimicrob. Chemother. 24, 311\u2013316 (1989).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2017102_CR69","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1021\/ja01192a520","volume":"70","author":"BD Davis","year":"1948","unstructured":"Davis, B. D. Isolation of biochemically deficient mutants of bacteria by penicillin. J. Am. Chem. Soc. 70, 4267\u20134267 (1948).","journal-title":"J. Am. Chem. Soc."},{"key":"BFja2017102_CR70","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1099\/00221287-132-5-1297","volume":"132","author":"E Tuomanen","year":"1986","unstructured":"Tuomanen, E., Cozens, R., Tosch, W., Zak, O. & Tomasz, A. The rate of killing of Escherichia coli by\u03b2-lactam antibiotics is strictly proportional to the rate of bacterial growth. Microbiology 132, 1297\u20131304 (1986).","journal-title":"Microbiology"},{"key":"BFja2017102_CR71","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.1099390","volume":"305","author":"NQ Balaban","year":"2004","unstructured":"Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622\u20131625 (2004).","journal-title":"Science"},{"key":"BFja2017102_CR72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro821","volume":"2","author":"L Hall-Stoodley","year":"2004","unstructured":"Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95\u2013108 (2004).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja2017102_CR73","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/AAC.46.5.1262-1268.2002","volume":"46","author":"Q Li","year":"2002","unstructured":"Li, Q. et al. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against \u03b2-lactamase-producing strains. Antimicrob. Agents Chemother. 46, 1262\u20131268 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017102_CR74","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrg2778","volume":"11","author":"RC MacLean","year":"2010","unstructured":"MacLean, R. C., Hall, A. R., Perron, G. G. & Buckling, A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11, 405\u2013414 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFja2017102_CR75","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1128\/EC.00048-06","volume":"5","author":"JB Anderson","year":"2006","unstructured":"Anderson, J. B., Ricker, N. & Sirjusingh, C. Antagonism between two mechanisms of antifungal drug resistance. Eukaryot. Cell 5, 1243\u20131251 (2006).","journal-title":"Eukaryot. Cell"},{"key":"BFja2017102_CR76","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/bies.10386","volume":"26","author":"MT Bretscher","year":"2004","unstructured":"Bretscher, M. T., Althaus, C. L., M\u00fcller, V. & Bonhoeffer, S. Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26, 180\u2013188 (2004).","journal-title":"Bioessays"},{"key":"BFja2017102_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0098-8472(92)90011-P","volume":"32","author":"GJ Taylor","year":"1992","unstructured":"Taylor, G. J., Stadt, K. J. & Dale, M. R. Modelling the interactive effects of aluminum, cadmium, manganese, nickel and zinc stress using the Weibull frequency distribution. Environ. Exp. Botany 32, 281\u2013293 (1992).","journal-title":"Environ. Exp. Botany"},{"key":"BFja2017102_CR78","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1094\/PHYTO-08-10-0216","volume":"101","author":"X-M Xu","year":"2011","unstructured":"Xu, X.-M., Jeffries, P., Pautasso, M. & Jeger, M. J. Combined use of biocontrol agents to manage plant diseases in theory and practice. Phytopathology 101, 1024\u20131031 (2011).","journal-title":"Phytopathology"},{"key":"BFja2017102_CR79","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jtbi.2009.07.033","volume":"261","author":"P Schenker","year":"2009","unstructured":"Schenker, P. & Baici, A. Simultaneous interaction of enzymes with two modifiers: reappraisal of kinetic models and new paradigms. J. Theor. Biol. 261, 318\u2013329 (2009).","journal-title":"J. Theor. Biol."},{"key":"BFja2017102_CR80","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ps.1353","volume":"63","author":"N Cedergreen","year":"2007","unstructured":"Cedergreen, N., Kudsk, P., Mathiassen, S. K. & Streibig, J. C. Combination effects of herbicides on plants and algae: do species and test systems matter? Pest Manag. Sci. 63, 282\u2013295 (2007).","journal-title":"Pest Manag. Sci."},{"key":"BFja2017102_CR81","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1073\/pnas.1511751112","volume":"112","author":"MA Farha","year":"2015","unstructured":"Farha, M. A. et al. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc. Natl Acad. Sci. USA 112, 11048\u201311053 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017102_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrmicro1835","volume":"6","author":"LE Cowen","year":"2008","unstructured":"Cowen, L. E. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 6, 187\u2013198 (2008).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja2017102_CR83","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrmicro1179","volume":"3","author":"JB Anderson","year":"2005","unstructured":"Anderson, J. B. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat. Rev. Microbiol. 3, 547\u2013556 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja2017102_CR84","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1158\/1078-0432.CCR-03-0707","volume":"10","author":"M Sui","year":"2004","unstructured":"Sui, M., Dziadyk, J. M., Zhu, X. & Fan, W. Cell cycle\u2013dependent antagonistic interactions between paclitaxel and \u03b3-radiation in combination therapy. Clin. Cancer Res. 10, 4848\u20134857 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFja2017102_CR85","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/BF01195344","volume":"119","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky, E. K., Citardi, M. J., Noe, D. A. & Donehower, R. C. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine. J. Cancer Res. Clin. Oncol. 119, 727\u2013733 (1993).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"BFja2017102_CR86","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2407-12-450","volume":"12","author":"C Ceran","year":"2012","unstructured":"Ceran, C., Cokol, M., Cingoz, S., Tasan, I., Ozturk, M. & Yagci, T. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-\u03b1. BMC Cancer 12, 450 (2012).","journal-title":"BMC Cancer"},{"key":"BFja2017102_CR87","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/sj.leu.2401623","volume":"13","author":"M Blagosklonny","year":"1999","unstructured":"Blagosklonny, M. Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal. Leukemia 13, 2031\u20132035 (1999).","journal-title":"Leukemia"},{"key":"BFja2017102_CR88","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1073\/pnas.1201281109","volume":"109","author":"K Wood","year":"2012","unstructured":"Wood, K., Nishida, S., Sontag, E. D. & Cluzel, P. Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc. Natl Acad. Sci. USA 109, 12254\u201312259 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"125","key":"BFja2017102_CR89","doi-asserted-by":"publisher","first-page":"20160800","DOI":"10.1098\/rsif.2016.0800","volume":"13","author":"Casey Beppler","year":"2016","unstructured":"Beppler, C. et al. Uncovering emergent interactions in three-way combinations of stressors. J. R. Soc. Interface 13 (2016).","journal-title":"Journal of The Royal Society Interface"},{"key":"BFja2017102_CR90","doi-asserted-by":"publisher","first-page":"10231","DOI":"10.1073\/pnas.1612365113","volume":"113","author":"KB Wood","year":"2016","unstructured":"Wood, K. B. Pairwise interactions and the battle against combinatorics in multidrug therapies. Proc. Natl Acad. Sci. USA 113, 10231\u201310233 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017102_CR91","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coisb.2017.05.015","volume":"4","author":"E Tekin","year":"2017","unstructured":"Tekin, E., Savage, V. M. & Yeh, P. J. Measuring higher-order drug interactions: a review of recent approaches. Curr. Opin. Syst. Biol. 4, 16\u201323 (2017).","journal-title":"Curr. Opin. Syst. Biol."},{"issue":"Supplement 3","key":"BFja2017102_CR92","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1086\/376524","volume":"37","author":"WJ Steinbach","year":"2003","unstructured":"Steinbach, W. J., Stevens, D. A. & Denning, D. W. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin. Infect. Dis. 37 (Supplement 3), S188\u2013S244 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2017102_CR93","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl, K. et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455, 804\u2013807 (2008).","journal-title":"Nature"},{"key":"BFja2017102_CR94","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey, G. A. & Sabath, L. D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38, 864\u2013870 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2017102_CR95","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.pmed.0030029","volume":"3","author":"KR Foster","year":"2006","unstructured":"Foster, K. R. & Grundmann, H. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med. 3, e29 (2006).","journal-title":"PLoS Med."},{"key":"BFja2017102_CR96","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","volume":"4","author":"LE Connolly","year":"2007","unstructured":"Connolly, L. E., Edelstein, P. H. & Ramakrishnan, L. Why is long-term therapy required to cure tuberculosis? PLoS Med. 4, e120 (2007).","journal-title":"PLoS Med."},{"key":"BFja2017102_CR97","doi-asserted-by":"publisher","first-page":"e80775","DOI":"10.1371\/journal.pone.0080775","volume":"8","author":"AL Gomes","year":"2013","unstructured":"Gomes, A. L., Galagan, J. E. & Segr\u00e8, D. Resource competition may lead to effective treatment of antibiotic resistant infections. PLoS ONE 8, e80775 (2013).","journal-title":"PLoS ONE"},{"key":"BFja2017102_CR98","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.tim.2015.01.005","volume":"23","author":"T Day","year":"2015","unstructured":"Day, T., Huijben, S. & Read, A. F. Is selection relevant in the evolutionary emergence of drug resistance? Trends Microbiol. 23, 126\u2013133 (2015).","journal-title":"Trends Microbiol."},{"key":"BFja2017102_CR99","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nrmicro1553","volume":"4","author":"RS Singer","year":"2006","unstructured":"Singer, R. S., Ward, M. P. & Maldonado, G. Can landscape ecology untangle the complexity of antibiotic resistance? Nat. Rev. Microbiol. 4, 943\u2013952 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja2017102_CR100","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122\u2013S129 (2004).","journal-title":"Nat. Med."},{"key":"BFja2017102_CR101","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0169-5347(96)20067-9","volume":"11","author":"VH Smith","year":"1996","unstructured":"Smith, V. H. & Holt, R. D. Resource competition and within-host disease dynamics. Trends Ecol. Evol. 11, 386\u2013389 (1996).","journal-title":"Trends Ecol. Evol."},{"key":"BFja2017102_CR102","first-page":"351","volume":"48","author":"Y Kano","year":"1988","unstructured":"Kano, Y., Ohnuma, T., Okano, T. & Holland, J. F. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res. 48, 351\u2013356 (1988).","journal-title":"Cancer Res."},{"key":"BFja2017102_CR103","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","volume":"11","author":"VP Torchilin","year":"2000","unstructured":"Torchilin, V. P. Drug targeting. Eur. J. Pharm. Sci. 11, S81\u2013S91 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"BFja2017102_CR104","doi-asserted-by":"publisher","first-page":"065007","DOI":"10.1088\/1478-3975\/9\/6\/065007","volume":"9","author":"PA Orlando","year":"2012","unstructured":"Orlando, P. A., Gatenby, R. A. & Brown, J. S. Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy. Phys. Biol. 9, 065007 (2012).","journal-title":"Phys. Biol."},{"key":"BFja2017102_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2015.05.008","volume":"27","author":"T Bollenbach","year":"2015","unstructured":"Bollenbach, T. Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution. Curr. Opin. Microbiol. 27, 1\u20139 (2015).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFja2017102_CR106","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/toxics3040342","volume":"3","author":"I Rodea-Palomares","year":"2015","unstructured":"Rodea-Palomares, I., Gonz\u00e1lez-Pleiter, M., Mart\u00edn-Betancor, K., Rosal, R. & Fern\u00e1ndez-Pi\u00f1as, F. Additivity and interactions in ecotoxicity of pollutant mixtures: some patterns, conclusions, and open questions. Toxics 3, 342\u2013369 (2015).","journal-title":"Toxics"},{"key":"BFja2017102_CR107","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12866-017-1017-3","volume":"17","author":"C Beppler","year":"2017","unstructured":"Beppler, C. et al. When more is less: emergent suppressive interactions in three-drug combinations. BMC Microbiol. 17, 107 (2017).","journal-title":"BMC Microbiol."},{"key":"BFja2017102_CR108","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe, S. The problem of synergism and antagonism of combined drugs. Arzneimittel-Forschung 3, 285 (1953).","journal-title":"Arzneimittel-Forschung"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2017102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2017.102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:03:43Z","timestamp":1750853023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2017102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFja2017102"],"URL":"https:\/\/doi.org\/10.1038\/ja.2017.102","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"assertion":[{"value":"11 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}